Mon 2 Nov 2026 13:15:18 BST
Search Company
*

Active Substance
New Active Substance
Search Site
--
*

Create Site
--
*
*
*
*
*
*
Update Site
Current data stored in EudraGMDP databaseCurrent data stored in OMS
--
Characters remaining:4000/4000
New Active Substance Importation
Active Substance*
Active Substance (English):
Active Substance (NL):
NCA Reference Key:
3rd Country Manufacturer
3rd Country ManufacturerOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

3rd Country Distributor
3rd Country DistributorOMS Location IdentifierOMS Organisation IdentifierLegal AddressNCA Reference KeyConfidentialEditDelete
No records found.

Information Messages
  • The WDA has been withdrawn, withdrawn date is: 2025-04-15
  • RTF Template


    National Agency For The Safety Of Medicine And Health Products

    UNION FORMAT FOR A WHOLESALE DISTRIBUTION AUTHORISATION

    Human medicinal products


    1. Authorisation Number

    :

    2023_187_1_2_4_10

    2. Name of Authorisation Holder

    :

    Eurofins Clinical Trial Supplies France

    (ORG-100040702 / LOC-100068044)

    3. Address(es) of Site(s)

    :

    Zone D Activite Du Charpenay, 10 Rue De L Aqueduc, Lentilly, 69210, France 




    4. Legally registered address of Authorisation Holder

    :

    Site De La Geraudiere, Rue Pierre Adolphe Bobierre, Nantes, 44300

    5. Scope of authorisation

    :

    ANNEX 1

    6. Legal basis of authorisation

    :

    Art. 77(1) of Directive 2001/83/EC

    7. Name of responsible officer of the competent authority of the member state granting the wholesale distribution authorisation

    :

    Confidential, Confidential

    8. Signature

    :


    9. Date

    :

    2023-08-21

    10. Annexes attached

    :

    Annex 1 Scope of wholesale distribution authorisation

    Annex 2 (Optional) Address(es) of contract wholesale distribution sites and their authorisation number

    Annex 3 (Optional) Name(s) of responsible person(s)

    Annex 4 (Optional) Date of Inspection on which authorisation was granted

    Annex 5 (Optional) Additional provisions based on national requirements


    ANNEX 1

    SCOPE OF WHOLESALE DISTRIBUTION AUTHORISATION



    Name and address of the site: Eurofins Clinical Trial Supplies France

    (ORG-100040702 / LOC-100066932)

    , Zone D Activite Du Charpenay, 10 Rue De L Aqueduc, Lentilly, 69210, France   



    Human medicinal products


    1. MEDICINAL PRODUCTS

       1.1. with a Marketing Authorisation in EEA country(s)

       1.2. without a Marketing Authorisation in the EEA and intended for EEA market

       1.3. without a Marketing Authorisation in the EEA and intended for exportation


    2. AUTHORISED WHOLESALE DISTRIBUTION OPERATIONS

       2.2. Holding 

       2.3. Supply 

       2.4. Export 


    3. MEDICINAL PRODUCTS WITH ADDITIONAL REQUIREMENTS

         3.1.1. Narcotic or psychotropic products 

         3.1.2. Medicinal products derived from blood 

         3.1.3. Immunological medicinal products 

       3.3. Cold chain products(requiring low temperature handling) 

       3.4. Other products: investigational medicinal products --- médicaments expérimentaux




    Any restrictions or clarifying remarks (for all users):  -
    Dépositaire (Public Health Code Article R.5124-2 4°) acting by order and on behalf of one or more "exploitants" of medicinal products other than investigational medicinal products, generators, kits and precursors (Article L.4211-1 3°); activity: storage with a view to the wholesale distribution without modification of medicines, products not owned by the company.
    Activity limited to cold chain products (3.3).

    Distributor of investigational medicinal products (Public Health Code Article R.5124-2 10°)
    Activity undertaken by order and on behalf of one or more sponsors as defined by Article L. 1121-1: storage operations with a view to the distribution without modification of investigational medicinal products manufactured or imported by companies or bodies as defined in paragraphs 1 and 2 of Article R. 5124-2.

    Signatory: Mrs F. Descamps-Delesalle, head of pharmaceutical product inspection and counterfeiting fight department
    The ANSM does not issue hard copy of this authorisation.
    ---

    Établissement dépositaire (code de la santé publique art. R.5124-2 4°) se livrant, d'ordre et pour le compte d'un ou plusieurs exploitants de médicaments, de générateurs, trousses ou précurseurs (art. L.4211-1 3°) au stockage de ces médicaments ou produits dont elle n'est pas propriétaire, en vue de leur distribution en gros et en l'état.
    Activité limitée aux produits de la chaîne du froid (3.3).

    Établissement distributeur de médicaments expérimentaux (code de la santé publique art. R.5124-2 10°) se livrant, le cas échéant d'ordre et pour le compte d'un ou plusieurs promoteurs définis à l'article L.1121-1, au stockage en vue de leur distribution en l'état de médicaments expérimentaux fabriqués ou importés par des entreprises ou organismes définis au 1° ou au 2° de l'article R.5124-2.

    Signataire : Mme F. Descamps-Delesalle, chef du Pôle inspection des produits pharmaceutiques et lutte contre les fraudes
    L'ANSM ne délivre pas de copie papier de cette autorisation.








    Reason for Withdrawing:

    replaced with authorisation 2025_112_1_2_4_10

    remplacée par l'autorisation 2025_112_1_2_4_10








    Union Format for a Wholesale Distribution Authorisation

    2023_187_1_2_4_10


    Page 1





    Loading, please wait